Department of Neuroscience and Cell Biology, University of Texas Medical Branch at Galveston, TX 77555, USA.
Exp Neurol. 2012 Apr;234(2):362-72. doi: 10.1016/j.expneurol.2011.10.010. Epub 2011 Oct 21.
In the spinal cord, neuron and glial cells actively interact and contribute to neurofunction. Surprisingly, both cell types have similar receptors, transporters and ion channels and also produce similar neurotransmitters and cytokines. The neuroanatomical and neurochemical similarities work synergistically to maintain physiological homeostasis in the normal spinal cord. However, in trauma or disease states, spinal glia become activated, dorsal horn neurons become hyperexcitable contributing to sensitized neuronal-glial circuits. The maladaptive spinal circuits directly affect synaptic excitability, including activation of intracellular downstream cascades that result in enhanced evoked and spontaneous activity in dorsal horn neurons with the result that abnormal pain syndromes develop. Recent literature reported that spinal cord injury produces glial activation in the dorsal horn; however, the majority of glial activation studies after SCI have focused on transient and/or acute time points, from a few hours to 1 month, and peri-lesion sites, a few millimeters rostral and caudal to the lesion site. In addition, thoracic spinal cord injury produces activation of astrocytes and microglia that contributes to dorsal horn neuronal hyperexcitability and central neuropathic pain in above-level, at-level and below-level segments remote from the lesion in the spinal cord. The cellular and molecular events of glial activation are not simple events, rather they are the consequence of a combination of several neurochemical and neurophysiological changes following SCI. The ionic imbalances, neuroinflammation and alterations of cell cycle proteins after SCI are predominant components for neuroanatomical and neurochemical changes that result in glial activation. More importantly, SCI induced release of glutamate, proinflammatory cytokines, ATP, reactive oxygen species (ROS) and neurotrophic factors trigger activation of postsynaptic neuron and glial cells via their own receptors and channels that, in turn, contribute to neuronal-neuronal and neuronal-glial interaction as well as microglia-astrocytic interactions. However, a systematic review of temporal and spatial glial activation following SCI has not been done. In this review, we describe time and regional dependence of glial activation and describe activation mechanisms in various SCI models in rats. These data are placed in the broader context of glial activation mechanisms and chronic pain states. Our work in the context of work by others in SCI models demonstrates that dysfunctional glia, a condition called "gliopathy", is a key contributor in the underlying cellular mechanisms contributing to neuropathic pain.
在脊髓中,神经元和神经胶质细胞积极地相互作用并有助于神经功能。令人惊讶的是,这两种细胞类型都具有相似的受体、转运体和离子通道,并且也产生相似的神经递质和细胞因子。神经解剖学和神经化学的相似性协同作用,以维持正常脊髓中的生理内稳态。然而,在创伤或疾病状态下,脊髓胶质细胞被激活,背角神经元变得过度兴奋,导致敏化的神经元-胶质回路。适应性不良的脊髓回路直接影响突触兴奋性,包括激活细胞内下游级联反应,导致背角神经元中增强的诱发和自发活动,结果是异常疼痛综合征的发展。最近的文献报道,脊髓损伤会导致背角中的胶质细胞激活;然而,大多数 SCI 后的胶质细胞激活研究都集中在短暂和/或急性时间点,从几个小时到 1 个月,以及损伤部位周围,损伤部位的几毫米头侧和尾侧。此外,胸段脊髓损伤会导致星形胶质细胞和小胶质细胞的激活,这有助于背角神经元的过度兴奋和脊髓损伤以上、损伤水平和损伤以下节段的中枢性神经病理性疼痛。胶质细胞激活的细胞和分子事件不是简单的事件,而是 SCI 后几种神经化学和神经生理学变化的结果。SCI 后离子失衡、神经炎症和细胞周期蛋白的改变是导致胶质细胞激活的神经解剖学和神经化学变化的主要成分。更重要的是,SCI 诱导的谷氨酸、促炎细胞因子、ATP、活性氧(ROS)和神经营养因子的释放,通过其自身的受体和通道触发突触后神经元和神经胶质细胞的激活,进而有助于神经元-神经元和神经元-神经胶质的相互作用以及小胶质细胞-星形胶质细胞的相互作用。然而,SCI 后胶质细胞激活的时间和空间的系统综述尚未完成。在这篇综述中,我们描述了胶质细胞激活的时间和区域依赖性,并描述了大鼠各种 SCI 模型中的激活机制。这些数据被置于胶质细胞激活机制和慢性疼痛状态的更广泛背景下。我们在 SCI 模型中与其他人合作的工作表明,功能失调的胶质细胞,即所谓的“神经胶质病”,是导致神经病理性疼痛的潜在细胞机制的关键贡献者。